184 related articles for article (PubMed ID: 12063463)
1. How common is severe pulmonary hypertension after pediatric cardiac surgery?
Lindberg L; Olsson AK; Jögi P; Jonmarker C
J Thorac Cardiovasc Surg; 2002 Jun; 123(6):1155-63. PubMed ID: 12063463
[TBL] [Abstract][Full Text] [Related]
2. Impact of respiratory syncytial virus infection on surgery for congenital heart disease: postoperative course and outcome.
Khongphatthanayothin A; Wong PC; Samara Y; Newth CJ; Wells WJ; Starnes VA; Chang AC
Crit Care Med; 1999 Sep; 27(9):1974-81. PubMed ID: 10507627
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for higher cost in congenital heart operations.
Ungerleider RM; Bengur AR; Kessenich AL; Liekweg RJ; Hart EM; Rice BA; Miller CE; Lockwood NW; Knauss SA; Jaggers J; Sanders SP; Greeley WJ
Ann Thorac Surg; 1997 Jul; 64(1):44-8; discussion 49. PubMed ID: 9236333
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension.
Barr FE; Tirona RG; Taylor MB; Rice G; Arnold J; Cunningham G; Smith HA; Campbell A; Canter JA; Christian KG; Drinkwater DC; Scholl F; Kavanaugh-McHugh A; Summar ML
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):319-26. PubMed ID: 17662768
[TBL] [Abstract][Full Text] [Related]
5. Correction of complete atrioventricular septal defects with the double-patch technique and cleft closure.
Alexi-Meskishvili V; Ishino K; Dähnert I; Uhlemann F; Weng Y; Lange PE; Hetzer R
Ann Thorac Surg; 1996 Aug; 62(2):519-24; discussion 524-5. PubMed ID: 8694616
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcome of congenital heart disease in Down's syndrome.
Lal PS; Chavan B; Devendran VR; Varghese R; Murmu UC; Kumar RS
Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):166-9. PubMed ID: 24532614
[TBL] [Abstract][Full Text] [Related]
7. [Surgical treatment and early-mid follow-up results of complete atrioventricular septal].
Cui HJ; Zhuang J; Chen JM; Cen JZ; Xu G; Wen SS
Zhonghua Wai Ke Za Zhi; 2017 Dec; 55(12):933-937. PubMed ID: 29224269
[No Abstract] [Full Text] [Related]
8. Surgery of the complete atrioventricular canal: relationship between age at operation, mitral regurgitation, size of the ventricular septum defect, additional malformations and early postoperative outcome.
Schaffer R; Berdat P; Stolle B; Pfammatter JP; Stocker F; Carrel T
Cardiology; 1999; 91(4):231-5. PubMed ID: 10545678
[TBL] [Abstract][Full Text] [Related]
9. [Surgical treatment results of congenital heart defects in children with Down's syndrome].
Calderón-Colmenero J; Flores A; Ramírez S; Patiño-Bahena E; Zabal C; García-Montes JA; Rizo S; Buendía A; Attie F
Arch Cardiol Mex; 2004; 74(1):39-44. PubMed ID: 15125265
[TBL] [Abstract][Full Text] [Related]
10. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients.
Beghetti M; Habre W; Friedli B; Berner M
Br Heart J; 1995 Jan; 73(1):65-8. PubMed ID: 7888265
[TBL] [Abstract][Full Text] [Related]
11. [Adults with congenital heart defects--clinical spectrum and surgical management].
Berdjis F; Brandl D; Uhlemann F; Hausdorf G; Lange L; Weng Y; Loebe M; Alexi V; Hetzer R; Lange PE
Herz; 1996 Oct; 21(5):330-6. PubMed ID: 9011542
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension.
Goldman AP; Delius RE; Deanfield JE; de Leval MR; Sigston PE; Macrae DJ
Ann Thorac Surg; 1996 Sep; 62(3):750-5. PubMed ID: 8784003
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management.
Bando K; Turrentine MW; Sharp TG; Sekine Y; Aufiero TX; Sun K; Sekine E; Brown JW
J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1600-7; discussion 1607-9. PubMed ID: 8975852
[TBL] [Abstract][Full Text] [Related]
14. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects.
Journois D; Pouard P; Mauriat P; Malhère T; Vouhé P; Safran D
J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1129-35. PubMed ID: 8159035
[TBL] [Abstract][Full Text] [Related]
15. Complete atrioventricular septal defect: outcome of pulmonary artery banding improved by adjustable device.
Dhannapuneni RR; Gladman G; Kerr S; Venugopal P; Alphonso N; Corno AF
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):179-82. PubMed ID: 20598323
[TBL] [Abstract][Full Text] [Related]
16. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
Raja SG; Danton MD; MacArthur KJ; Pollock JC
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
[TBL] [Abstract][Full Text] [Related]
17. The effect of intravenous iloprost on pulmonary artery hypertension after paediatric congenital heart surgery.
Onan IS; Ozturk E; Yildiz O; Altin HF; Odemis E; Erek E
Interact Cardiovasc Thorac Surg; 2016 Feb; 22(2):194-9. PubMed ID: 26604214
[TBL] [Abstract][Full Text] [Related]
18. [Surgical treatment of congenital heart defects with pulmonary hypertension in children during their 1st year of life under the conditions of extracorporeal circulation].
Aleksi-Meskhishvili VV; Sharykin AS; Popov SA; Nikoliuk AP
Grudn Khir; 1989; (3):9-13. PubMed ID: 2744615
[TBL] [Abstract][Full Text] [Related]
19. Timing of neonatal cardiac surgery is not associated with perioperative outcomes.
Kumar TK; Charpie JR; Ohye RG; Hirsch-Romano JC; Donohue JE; Yu S; Sood V; Wilkinson DA; Nelson K; Mitchell E; Goldberg CS; Gaies MG
J Thorac Cardiovasc Surg; 2014 May; 147(5):1573-9. PubMed ID: 23988282
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations.
Goldman AP; Delius RE; Deanfield JE; Macrae DJ
Ann Thorac Surg; 1995 Aug; 60(2):300-5; discussion 306. PubMed ID: 7646090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]